ARPC1A Promotes NSCLC Malignancy via Stimulating the Drug Resistance and Cell Migration
Objectives: Non-small cell lung cancer (NSCLC) represents a formidable malignancy characterized by its marked metastatic potential and intrinsic resistance to therapeutic interventions. The identification of potential biomark... | Find, read and cite all the research you need on Tech Science Press
Authors
- Ru Yan (ORCID: https://orcid.org/0000-0001-6268-360X)
- Tianjing Zhang
- Hongjuan Guo
- Minxia Liu (ORCID: https://orcid.org/0000-0001-6667-7813)
- Dan Liu (ORCID: https://orcid.org/0000-0002-2198-3910)
- Kecheng Zhou (ORCID: https://orcid.org/0009-0005-4307-9745)
Publication Details
- Journal
- Biocell
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/biocell.2025.062143
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00